PS

PharmaSGP Holding SEMUN PharmaSGP Holding Stock Report

Last reporting period 30 Jun, 2024

Updated 11 Nov, 2024

Last price

Market cap $B

0.44

Micro

Exchange

XMUN - Boerse Muenchen

PSG.MU Stock Analysis

PS

Neutral

Based on Eyestock quantitative analysis, PSG.MU`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

80/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

59.4 %

Undervalued

Market cap $B

0.44

Dividend yield

8.04 %

Shares outstanding

12 B

PharmaSGP Holding SE engages in the sale and marketing of non-prescription drugs, chemical-free over-the-counter painkillers, as well as herbal medicines. The company is headquartered in Graefelfing, Bayern. The company went IPO on 2020-06-19. The firm produces and develops non-chemical and over-the-counter drugs and other healthcare products.

View Section: Eyestock Rating